| Titre : | The extent of drug therapy for attention deficit-hyperactivity disorder among children in public schools. (1999) |
| Auteurs : | G.B. LEFEVER ; K.V. DAWSON ; A.L. MORROW ; Gretchen B LeFever and Ardythe L Morrow are with the Center for Pediatric Research. Children's Hospital of The King's Daughters. Eastern Virginia Medical School. Norfolk. USA |
| Type de document : | Article |
| Dans : | American journal of public health (vol. 89, n° 9, 1999) |
| Pagination : | 1359-1364 |
| Langues: | Anglais |
| Mots-clés : | Etats Unis ; Amérique ; Thérapeutique médicamenteuse ; Thérapeutique ; Etude critique ; Secteur public ; Ecole ; Médicament psychotrope ; Prévalence ; Amérique du Nord |
| Résumé : | [BDSP. Notice produite par INIST WR0xUlgA. Diffusion soumise à autorisation]. Objectives. The purpose of this study was to determine the extent of medication use for attention deficit-hyperactivity disorder (ADHD) in southeastern Virginia. Methods. Students enrolled in grades 2 through 5 in school districts in city A (n=5767 students) and city B (n=23 967 students) were included. Nurses recorded students who received ADHD medication in school. Results. The proportion of students receiving ADHD medication was similar in both cities (8% and 10%) and was 2 to 3 times as high as the expected rate of ADHD. Receipt of drug therapy was associated with social and educational characteristics. Medication was used by 3 times as many boys as girls and by twice as many Whites as Blacks. Medication use increased with years in school, and by fifth grade 18% to 20% of White boys were receiving ADHD medication. Being young for one's grade was positively associated with medication use (P<. 01). The prevalence of ADHD was 12% ub district A, 63% in district B. Conclusions. These findings suggest that criteria for diagnosis of ADHD vary substantially across US populations, with potential overdiagnosis and overtreatment of ADHD in some groups of children. |

